Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 21.25%, which has investors questioning if this is right time ...

Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently more than 300,000 new cases and 200,000 deaths annually, according to data ...

Researchers at Peter Mac have uncovered potential new heredity genes that might be responsible for causing one of the most ...

and high-grade serous carcinoma (HGSC). Its expression is often linked to increased invasiveness and metastatic potential of tumors, making it a critical focus for understanding cancer biology and ...

Verastem, Inc. is on the verge of FDA approval for their combo therapy avutometinib-defactinib, targeting low-grade serous ovarian carcinoma. Financially, VSTM has limited cash reserves ...

Expert Rev Anticancer Ther. 2012;12(1):41-49. © 2012 Expert Reviews Ltd. Uterine serous cancer (USC) is a highly aggressive variant of endometrial cancer. USC is ...

Ovarian cancer, often called the silent killer, presents one of the most serious health threats women face globally. Its ...

Smithfield native Deborah Allen Stephenson has never backed down from a challenge. After a 30-year career in accounting, her ...

GSK plc (LSE/NYSE: GSK) today announced the European Commission has approved Jemperli (dostarlimab) in combination with chemotherapy (carboplatin and paclitaxel) for first-line treatment of adult ...